Allspring Global Investments Holdings, LLC Arvinas, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 7,371 shares of ARVN stock, worth $202,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,371
Previous 14,298
48.45%
Holding current value
$202,702
Previous $380,000
52.37%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ARVN
# of Institutions
221Shares Held
68.8MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$185 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$183 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$172 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$110 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$82.2 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.46B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...